Vapogenix
Stage
Unattributed VC | AliveTotal Raised
$18.83MLast Raised
$1.63M | 5 yrs agoAbout Vapogenix
Vapogenix is an early stage company focused on developing novel, non-opioid analgesics for acute and chronic pain management. Vapogenix's licensed technology covers novel formulations of known medications through new routes of administration for new indications, with the aim of creating potent analgesic and anti-inflammatory drugs. The company's lead product, VPX-595, is a compound being developed initially for the treatment of acute pain.
Missing: Vapogenix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Vapogenix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Vapogenix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Vapogenix is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Vapogenix Patents
Vapogenix has filed 8 patents.
The 3 most popular patent topics include:
- NMDA receptor antagonists
- Analgesics
- Anesthesia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/8/2020 | 4/19/2022 | Analgesics, NMDA receptor antagonists, General anesthetics, Anesthesia, Ethers | Grant |
Application Date | 5/8/2020 |
|---|---|
Grant Date | 4/19/2022 |
Title | |
Related Topics | Analgesics, NMDA receptor antagonists, General anesthetics, Anesthesia, Ethers |
Status | Grant |
Latest Vapogenix News
Nov 16, 2020
Vapogenix raising millions to develop non-opioid pain relief drug, gets federal grantHouston Business Journal -
Vapogenix Frequently Asked Questions (FAQ)
Where is Vapogenix's headquarters?
Vapogenix's headquarters is located at 8285 El Rio St, Houston.
What is Vapogenix's latest funding round?
Vapogenix's latest funding round is Unattributed VC.
How much did Vapogenix raise?
Vapogenix raised a total of $18.83M.
Who are the investors of Vapogenix?
Investors of Vapogenix include Pamoja Capital, Green Park & Golf Ventures and IrishAngels.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.